Hydrodynamic characterizations of estrogen receptors complexed with 3H -4-hydroxytamoxifen: evidence in support of contrasting receptor transitions mediated by different ligands.

Hydrodynamic characterizations of estrogen receptors complexed with 3H -4-hydroxytamoxifen: evidence in support of contrasting receptor transitions mediated by different ligands.

[Anonymous].  1985.  Hydrodynamic characterizations of estrogen receptors complexed with 3H -4-hydroxytamoxifen: evidence in support of contrasting receptor transitions mediated by different ligands.. Biochemistry. 24(27):8101-6.

Programming for the DNA analysis of FCM data on an IBM microcomputer.

Adjuvant vincristine, dactinomycin, and cyclophosphamide therapy in stage I uterine sarcomas. A pilot study.

Antagonism to estradiol in the mouse: reduced entry of receptors complexed with 4-hydroxytamoxifen into a Mg2+-soluble chromatin fraction.

Antagonism to estradiol in the mouse: reduced entry of receptors complexed with 4-hydroxytamoxifen into a Mg2+-soluble chromatin fraction.

[Anonymous].  1986.  Antagonism to estradiol in the mouse: reduced entry of receptors complexed with 4-hydroxytamoxifen into a Mg2+-soluble chromatin fraction.. Endocrinology. 118(5):1924-34.

Phase II clinical trial using californium 252 fast neutron brachytherapy, external pelvic radiation, and extrafascial hysterectomy in the treatment of bulky, barrel-shaped stage IB cervical cancer.

Phase II clinical trial using californium 252 fast neutron brachytherapy, external pelvic radiation, and extrafascial hysterectomy in the treatment of bulky, barrel-shaped stage IB cervical cancer.

[Anonymous].  1986.  Phase II clinical trial using californium 252 fast neutron brachytherapy, external pelvic radiation, and extrafascial hysterectomy in the treatment of bulky, barrel-shaped stage IB cervical cancer.. Cancer. 57(10):1918-22.

The effects of acute administration of cytotoxic anticancer agents on the capacity for subsequent hormonal responses in the mouse uterus.

The effects of acute administration of cytotoxic anticancer agents on the capacity for subsequent hormonal responses in the mouse uterus.

[Anonymous].  1986.  The effects of acute administration of cytotoxic anticancer agents on the capacity for subsequent hormonal responses in the mouse uterus.. Journal of steroid biochemistry. 25(2):231-7.

Extensive in situ activation of nuclear estrogen receptors after exposure of murine uteri to 3H estradiol or 3H 4-hydroxytamoxifen.

Phase I-II clinical trial of Californium-252. Treatment of stage IB carcinoma of the cervix.

Identification of a very large nuclear estrogen receptor complex.

Endometrial cancer following radiation therapy for cervical cancer.